P656: NOVEL THIAZOLIDINEDIONE WITH HDAC INHIBITING PROPERTIES OPTIMIZED FOR CHRONIC MYELOID LEUKEMIA TREATMENT

• Anna Rams,
• Paulina Laskowska,
• Adrianna Cieloch,
• Kalpana Tilekar,
• Neha Upadhyay,
• C.S. Ramaa,
• Piotr Mrowka,
• Eliza Głodkowska-Mrówka

Affiliations

Anna Rams

1 Institute of Hematology and Transfusion Medicine, Department of Experimental Hematology, Warsaw, Poland

Paulina Laskowska

1 Institute of Hematology and Transfusion Medicine, Department of Experimental Hematology, Warsaw, Poland

Adrianna Cieloch

2 Medical University of Warsaw, Department of Laboratory Medicine and Clinical Immunology of Developmental Age, Warsaw, Poland

Kalpana Tilekar

3 Bharati Vidyapeeth’s College of Pharmacy, Department of Pharmaceutical Chemistry, Navi Mumbai, India

Neha Upadhyay

3 Bharati Vidyapeeth’s College of Pharmacy, Department of Pharmaceutical Chemistry, Navi Mumbai, India

C.S. Ramaa

3 Bharati Vidyapeeth’s College of Pharmacy, Department of Pharmaceutical Chemistry, Navi Mumbai, India

Piotr Mrowka

1 Institute of Hematology and Transfusion Medicine, Department of Experimental Hematology, Warsaw, Poland

Eliza Głodkowska-Mrówka

1 Institute of Hematology and Transfusion Medicine, Department of Experimental Hematology, Warsaw, Poland